Ten-year kidney and pancreas graft survival for SPK transplantation from pediatric donors were 80% and 72%, respectively, compared to 61% pancreas and kidney graft survival from adult donors.
This report quantifies the complication risk in living donor liver transplants and should be used to inform decision making by potential donors and their caregivers.
To my knowledge, Prograf should be used as an intravenous (IV) drip for as short a time as possible. What is the reason for this recommendation, and what are the potential side effects of a long-term IV Prograf drip? What can prevent that side effect?
I would like to know your position on the indication of combined liver-kidney transplantation for patients in end-stage renal disease with Child's class A cirrhosis and no history of decompensation.
Assuming that he does have Alport syndrome, I have 2 questions: (1) Should he be relisted for transplantation and if so, what is the chance of a similar outcome?, and (2) Prior to this graft his father was being considered as a living donor; should he be considered again?
Simultaneous pancreas-kidney transplant is the only proven long-term therapeutic approach for diabetic patients with end-stage renal disease, and now HIV-positive candidates may have new hope.
What are the options for renal transplant vascular anastomosis in patient who underwent right nephrectomy and uretero-cystoplasty along with appendico-vesicostomy with stoma in the right iliac region?
Learn about the risk factors for tumor recurrence after liver transplantation -- in cirrhotic patients found to have an intrahepatic cholangiocarcinoma.
A patient has a type 4 hypersensitivity reaction to parabens, nickel, etc. He recently received a bovine pericardial aortic valve transplant for calcific aortic stenosis. Will this bioprosthetic graft also submit to accelerated calcific stenosis?
The patient has done well so far (2 months posttransplantation). Should I expect complications related specifically to the use of the PTFE for arterial revascularization?
I am a practicing gastroenterologist in Cebu City, Philippines. Liver cancer is one of the most common malignancies I see in my area. Can you tell me where in the United States liver transplantation for hepatocellular carcinoma (HCC) is performed and what is required of patients if they do opt for t